Sort
21,453 grants matching “tuberculosis”
Hospital and Household Studies of Respiratory Cryptosporidiosis and Transmission
$675,368Jeffrey K Griffiths · Tufts University Boston · R01 · FY2016 · AI
Lung Ultrasound and Artificial Intelligence Technology for the Diagnosis of TB in LMICs
$675,306Robert H Gilman · Johns Hopkins University · R01 · FY2024 · HL
A Rapid Phenotypic Drug Susceptibility Testing System for Tuberculosis
$675,156Mireille Kamariza · University Of California Los Angeles · R01 · FY2024 · AI
Defining how the spectrum of latency affects reactivation of TB
$675,044Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · HL
Oral Microbiome and Lung Cancer Risk
$674,957Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2016 · CA
Dynamics of the cellular and molecular architecture of human pulmonary TB granulomas
$674,955Robert L Modlin · University Of California Los Angeles · R01 · FY2022 · AI
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure
$674,625Christina Louise Lancioni · Oregon Health & Science University · R01 · FY2022 · AI
Mycobacterium tuberculosis antigen diversity
$674,536Joel D. Ernst · New York University School Of Medicine · R01 · FY2011 · AI
Evaluating health and economic effects of targeted strategies in TB/HIV
$674,488Theodore H Cohen · Yale University · R01 · FY2014 · AI
Expression signatures of TB-specific memory responses within the human lung
$674,453Richard F Silver · Case Western Reserve University · R01 · FY2013 · HL
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$674,402Shabaana A. Khader · Washington University · R01 · FY2021 · AI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$674,402Shabaana A. Khader · Washington University · R01 · FY2019 · AI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$674,402Shabaana A. Khader · Washington University · R01 · FY2020 · AI
Inhibitors of latent M. tuberculosis
$674,231Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2011 · AI
Anti-TB sterilizing immunity in immune and HIV+ individuals
$674,207Zheng W Chen · University Of Illinois At Chicago · R01 · FY2017 · HL
Host Response to TB and AIDS
$673,923New York University School Of Medicine · R01 · FY2005 · HL
Diagnostics and Pharmacotherapy for Severe Forms of TB
$673,914Scott K Heysell · University Of Virginia · U01 · FY2016 · AI
Trial of Vitamin D Supplementation to Prevent TB Infection in Schoolchildren
$673,745Ganmaa Davaasambuu · Harvard School Of Public Health · R01 · FY2018 · HL
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
$673,634Eric R Houpt · University Of Virginia · R01 · FY2023 · HL
Deep sequencing of pathogens to precisely define transmission networks using rare variants
$673,574William Hanage · Harvard School Of Public Health · R01 · FY2017 · AI
Advancing innovative therapies against pandrug-resistant Gram-negative superbugs
$673,485Qi Zhou · Purdue University · R01 · FY2019 · AI
Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.
$673,476Jonathan E Golub · Johns Hopkins University · U01 · FY2021 · CA
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$673,334Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Mechanism Based Inhibition of M Tuberculosis Enzymes
$673,080John S Blanchard · Albert Einstein College Of Medicine · R01 · FY2010 · AI
INNOVATIVE APPROACHES TO TUBERCULOSIS CONTROL
$673,072Johns Hopkins University · U19 · FY2001 · AI